Resumen
Propósito: la neuropatía periférica tiene un espectro clínico inespecífico y multifactorial, con frecuente subdiagnóstico y terapéutica de eficacia variable. Existe una heterogénea prescripción de vitaminas B, las cuales pueden desempeñar un rol importante en el manejo de diferentes neuropatías; sin embargo, en Colombia no existen guías clínicas al respecto. El propósito de este trabajo es orientar en el reconocimiento temprano de las neuropatías periféricas y genera recomendaciones sobre el uso adecuado de vitaminas B neurotrópicas.
Descripción de la metodología: acuerdo de expertos sobre la neuropatía periférica y el rol terapéutico de las vitaminas B con énfasis en la epidemiología en Colombia, diagnóstico y tratamiento.
Contenidos: en Colombia, la prevalencia de neuropatía periférica se estima en alrededor del 10?%, sin embargo, no hay datos recientes. Dentro de las etiologías más frecuentes se encuentran la neuropatía diabética, infecciosas, inflamatorias, carenciales, toxicas y farmacológicas. Se recomiendan las siguientes herramientas de tamizaje en población de riesgo: DN4, MNSI, test de monofilamento, test de vibración y valoración de reflejos. Las vitaminas B1, B6 y B12 son seguras, accesibles y pueden ser eficaces en neuropatía periférica, incluso cuando el déficit no ha sido demostrado, pero con requerimientos particulares en su administración conjunta.
Conclusiones: las neuropatías periféricas son un reto diagnóstico y terapéutico que requiere la identificación oportuna para el tratamiento de la etiología subyacente y el control de síntomas. El uso de vitaminas B neurotrópicas es efectivo y seguro en neuropatía periférica carencial, y también parece ser eficaz en el manejo de neuropatías periféricas de diferentes etiologías.
Citas
Calderón-Ospina CA, Franco-González HG, Leal-Martínez F, Orozco-Vázquez AH, Plascencia-Pérez S, Sánchez-Mijangos JH. Uso clínico de las vitaminas B neurotrópicas en enfermedades del sistema nervioso periférico en México y América Central. Med Int Méx. 2022;38(4):887–902. https://doi.org/10.24245/mim.v38i4.5133
Hammi C, Yeung B. Neuropathy. StatPearls, Treasure Island (FL): StatPearls Publishing; 2022.
Callaghan BC, Price RS, Chen KS, Feldman EL. The importance of rare subtypes in diagnosis and treatment of peripheral neuropathy. JAMA Neurol. 2015;72:1510. https://doi.org/10.1001/jamaneurol.2015.2347.
Hanewinckel R, van Oijen M, Ikram MA, van Doorn PA. The epidemiology and risk factors of chronic polyneuropathy. Eur J Epidemiol 2016;31:5–20. https://doi.org/10.1007/s10654-015-0094-6.
de Moraes Vieira EB, Garcia JBS, da Silva AAM, Mualem Araújo RLT, Jansen RCS. Prevalence, characteristics, and factors associated with chronic pain with and without neuropathic characteristics in São Luís, Brazil. J Pain Symptom Manage. 2012;44:239–51. https://doi.org/10.1016/j.jpainsymman.2011.08.014
Savettieri G, Rocca WA, Salemi G, Meneghini F, Grigoletto F, Morgante L, et al. Prevalence of diabetic neuropathy with somatic symptoms. Neurology. 1993;43:1115. https://doi.org/10.1212/WNL.43.6.1115
Azhary H, Farooq MU, Bhanushali M, Majid A, Kassab MY. Peripheral neuropathy: differential diagnosis and management. Am Fam Physician. 2010;81:887–92.
Castelli G, Desai KM, Cantone RE. Peripheral neuropathy: evaluation and differential diagnosis. Am Fam Physician. 2020;102:732–9.
Yovera-Aldana M, Velásquez-Rimachi V, Huerta-Rosario A, More-Yupanqui MD, Osores-Flores M, Espinoza R, et al. Prevalence and incidence of diabetic peripheral neuropathy in Latin America and the Caribbean: A systematic review and meta-analysis. PLoS One. 2021;16:e0251642. https://doi.org/10.1371/journal.pone.0251642
Alcivar Alcivar DJ, Alvarado Cruz MS, Merchán Villafuerte KM, Journal of Scientific Research M. Prevalencia de neuropatía periférica en pacientes con diabetes mellitus tipo 2. MQRInvestigar. 2022;6:23–41. https://doi.org/10.56048/MQR20225.6.2.2022.23-41
Oliveros-Lijap L, Ávila-Espinoza P, Ulloa V, Bernabe-Ortiz A. Calidad de vida en pacientes con neuropatía diabética periférica: estudio transversal en Lima, Perú. Acta Med Peru. 2018;35:160-167. http://www.scielo.org.pe/scielo.php?script=sci_abstract&pid=S1728-59172018000300004&lng=es&nrm=iso&tlng=pt
Sun J, Wang Y, Zhang X, Zhu S, He H. Prevalence of peripheral neuropathy in patients with diabetes: A systematic review and meta-analysis. Prim Care Diabetes. 2020;14:435–44. https://doi.org/10.1016/j.pcd.2019.12.005
Souza LR de, Debiasi D, Ceretta LB, Simãµes PW, Tuon L. Meta-analysis and meta-regression of the prevalence of diabetic peripheral neuropathy among patients with type 2 diabetes mellitus. Int Arch Med. 2016;9. https://doi.org/10.3823/1936
Barrell K, Smith AG. Peripheral neuropathy. Med Clin North Am. 2019;103:383–97. https://doi.org/10.1016/j.mcna.2018.10.006
Rahman S, Baumgartner M. B vitamins: small molecules, big effects. J Inherit Metab Dis. 2019;42:579–80. https://doi.org/10.1002/jimd.12127
Peterson CT, Rodionov DA, Osterman AL, Peterson SN. B Vitamins and their role in immune regulation and cancer. Nutrients. 2020;12:3380. https://doi.org/10.3390/nu12113380
Calderón-Ospina CA, Nava-Mesa MO. B Vitamins in the nervous system: Current knowledge of the biochemical modes of action and synergies of thiamine, pyridoxine, and cobalamin. CNS Neurosci Ther. 2020;26:5–13. https://doi.org/10.1111/cns.13207
Kennedy DO. B Vitamins and the brain: mechanisms, dose and efficacy–a review. Nutrients. 2016;8:68. https://doi.org/10.3390/nu8020068
Uebanso T, Shimohata T, Mawatari K, Takahashi A. Functional roles of B-vitamins in the gut and gut microbiome. Mol Nutr Food Res. 2020;64:e2000426. https://doi.org/10.1002/mnfr.202000426
Baltrusch S. The role of neurotropic B vitamins in nerve regeneration. Biomed Res Int. 2021;2021:9968228. https://doi.org/10.1155/2021/9968228
Pradilla AG, Vesga A. BE, León-Sarmiento FE. Estudio neuroepidemiológico nacional (Epineuro) colombiano. Rev Panam Salud Pública. 2003;14:104–11. https://doi.org/10.1590/S1020-49892003000700005
Díaz-Cabezas R, Ruano-Restrepo MI, Chacón-Cardona JA, Vera-González A. Perfil neuroepidemiológico en la zona centro del departamento de Caldas (Colombia), años 2004-2005. Rev Neurol. 2006:646–52.
Takeuchi Y, Guevara JG. Prevalencia de las enfermedades neurológicas en el Valle del Cauca. Estudio neuroepidemiológico nacional (Epineuro). Colomb Med. 1999;30:74–81.
Díaz R, Marulanda Mejía F.Chronic nociceptive and neuropathic pain in adult population in Manizales (Colombia). Acta Med Colomb. 2011;36:10-17.
Magliano DJ, Boyko EJ. IDF diabetes atlas. 10.a edición. Bruselas: International Diabetes Federation; 2021.
Martinez JW, Sanchez-Naranjo JC, Londono-De Los Rios PA, Isaza-Mejia CA, Sosa-Urrea JD, Martinez-Munoz MA, et al. Prevalence of peripheral neuropathy associated with chemotherapy in four oncology centers of Colombia. Rev Neurol. 2019;69:94–8. https://doi.org/10.33588/rn.6903.2019035
Gómez Á, Díaz A, Carrión?Penagos J, Reyes J, Reyes S. Clinical and electrophysiological characteristics of Guillain?Barré syndrome in Colombia. J Peripher Nerv Syst. 2019;24:268–71. https://doi.org/10.1111/jns.12340
Bardach AE, Palermo C, Alconada T, Sandoval M, Balan DJ, Nieto Guevara J, et al. Herpes zoster epidemiology in Latin America: A systematic review and meta-analysis. PLoS One. 2021;16:e0255877. https://doi.org/10.1371/journal.pone.0255877
Finsterer J. Management of peripheral facial nerve palsy. Eur Arch Otorhinolaryngol. 2008;265:743–52. https://doi.org/10.1007/s00405-008-0646-4
Nicholas PK, Kemppainen JK, Canaval GE, Corless IB, Sefcik EF, Nokes KM, et al. Symptom management and self-care for peripheral neuropathy in HIV/AIDS. AIDS Care. 2007;19:179–89. https://doi.org/10.1080/09540120600971083
Serrano-Coll H, Mieles O, Escorcia C, Díaz A, Beltrán C, Cardona-Castro N. A case series of pure neural leprosy in patients diagnosed in a specialized center for the control of Hansen’s disease in Colombia. Biomédica. 2018;38:153–61. https://doi.org/10.7705/biomedica.v38i0.3690
Rodriguez G, Pinto R, Gomez Y, Rengifo ML, Estrada OL, Sarmiento M, et al. Pure neuritic leprosy in patients from a high endemic region of Colombia. Lepr Rev. 2013;84:41–50.
Moutran-Barroso H, Kreinter-Rosembaun H, Zafra-Sierra MP, Ramírez-Arquez E, Martínez-Rubio C. Multiple cranial neuropathy: Clinical findings in a case series of 142 patients. Mult Scler Relat Disord. 2022;65:103997. https://doi.org/10.1016/j.msard.2022.103997
DeFronzo RA, Ferrannini E, Groop L, Henry RR, Herman WH, Holst JJ, et al. Type 2 diabetes mellitus. Nat Rev Dis Primers. 2015;1:15019. https://doi.org/10.1038/nrdp.2015.19
International Diabetes Federation. IDF Diabetes atlas, 10.a edición, 2011. Colombia diabetes report 2000-2045. https://diabetesatlas.org/data/en/country/43/co.html
Martínez Marín JD, Henao Riveros SC, Rey Tovar MH. Niveles de vitamina B12 en pacientes colombianos con gastritis crónica atrófica. Rev Colomb Gastroenterol. 2010;25:261–4.
De Espronceda Ezquerro I, Oscoz Jaime S, Yanguas Bayona JI. Vitamin B12-induced acne. Med Clin (Barc). 2018;151:e15. https://doi.org/10.1016/j.medcli.2018.01.002
De la Espriella Guerrero RA, Rodríguez V, Rincón CJ, Cabrera Morales D, Pérez Rodríguez SJ, Gómez-Restrepo C. Consumo de alcohol en la población colombiana. Encuesta Nacional de Salud Mental. 2015. Rev Colomb Psiquiatr. 2016;45:76–88. https://doi.org/10.1016/j.rcp.2016.05.002
Julian T, Glascow N, Syeed R, Zis P. Alcohol-related peripheral neuropathy: a systematic review and meta-analysis. J Neurol. 2019;266:2907–19. https://doi.org/10.1007/s00415-018-9123-1
Chopra K, Tiwari V. Alcoholic neuropathy: possible mechanisms and future treatment possibilities. Br J Clin Pharmacol. 2012;73:348–62. https://doi.org/10.1111/j.1365-2125.2011.04111.x
Nold CS, Nozaki K. Peripheral neuropathy: Clinical pearls for making the diagnosis. JAAPA. 2020;33:9–15. https://doi.org/10.1097/01.JAA.0000615460.45150.e0
Ziegler D, Tesfaye S, Spallone V, Gurieva I, Al Kaabi J, Mankovsky B, et al. Screening, diagnosis and management of diabetic sensorimotor polyneuropathy in clinical practice: International expert consensus recommendations. Diabetes Res Clin Pract. 2022;186:109063. https://doi.org/10.1016/j.diabres.2021.109063
Spallone V, Morganti R, D’Amato C, Greco C, Cacciotti L, Marfia GA. Validation of DN4 as a screening tool for neuropathic pain in painful diabetic polyneuropathy. Diabet Med. 2012;29:578–85. https://doi.org/10.1111/j.1464-5491.2011.03500.x
Herman WH, Pop?Busui R, Braffett BH, Martin CL, Cleary PA, Albers JW, et al. Use of the Michigan neuropathy screening instrument as a measure of distal symmetrical peripheral neuropathy in type?1 diabetes: results from the diabetes control and complications trial/epidemiology of diabetes interventions and complications. Diabetic Medicine. 2012;29:937–44. https://doi.org/10.1111/j.1464-5491.2012.03644.x
Blanco E, Gálvez R, Zamorano E, López V, Pérez M. Prevalencia del dolor neuropático (DN), según DN4, en atención primaria. Semergen. 2012;38:203–10. https://doi.org/10.1016/j.semerg.2011.10.012
Carmichael J, Fadavi H, Ishibashi F, Shore AC, Tavakoli M. Advances in screening, early diagnosis and accurate staging of diabetic neuropathy. Front Endocrinol (Lausanne). 2021;12:671257. https://doi.org/10.3389/fendo.2021.671257
Stewart JD, Low PA, Fealey RD. Distal small fiber neuropathy: results of tests of sweating and autonomic cardiovascular reflexes. Muscle Nerve. 1992;15:661–5. https://doi.org/10.1002/mus.880150605
Magda P, Latov N, Renard M V, Sander HW. Quantitative sensory testing: high sensitivity in small fiber neuropathy with normal NCS/EMG. J Peripher Nerv Syst. 2002;7:225–8. https://doi.org/10.1046/j.1529-8027.2002.02029.x
Krumova EK, Geber C, Westermann A, Maier C. Neuropathic pain: is quantitative sensory testing helpful? Curr Diab Rep. 2012;12:393–402. https://doi.org/10.1007/s11892-012-0282-7
Shahrizaila N, Lehmann HC, Kuwabara S. Guillain-Barré syndrome. Lancet. 2021;397:1214–28. https://doi.org/10.1016/S0140-6736(21)00517-1
Morena J, Gupta A, Hoyle JC. Charcot-Marie-Tooth: From molecules to therapy. Int J Mol Sci. 2019;20:3419. https://doi.org/10.3390/ijms20143419
Keddie S, Lunn MP. POEMS syndrome. Curr Opin Neurol. 2018;31:551–8. https://doi.org/10.1097/WCO.0000000000000610
Beadon K, Guimarães-Costa R, Léger JM. Multifocal motor neuropathy. Curr Opin Neurol. 2018;31:559–64. https://doi.org/10.1097/WCO.0000000000000605
Niimi N, Takaku S, Yako H, Sango K. Drug-induced demyelinating neuropathies. Adv Exp Med Biol. 2019;1190:357–69. https://doi.org/10.1007/978-981-32-9636-7_23
Romagnolo A, Merola A, Artusi CA, Rizzone MG, Zibetti M, Lopiano L. Levodopa-induced neuropathy: a systematic review. Mov Disord Clin Pract. 2019;6:96–103. https://doi.org/10.1002/mdc3.12688
DynaMed. Peripheral Neuropathy. EBSCO Information Services. 2023 Dic 1. https://www.dynamed.com/condition/peripheral-neuropathy#GUID-7EF994DF-B7FF-4CEA-9861-D05226EC5FD3
Gwathmey KG, Pearson KT. Diagnosis and management of sensory polyneuropathy. BMJ. 2019;365:l1108. https://doi.org/10.1136/bmj.l1108
Iqbal Z, Azmi S, Yadav R, Ferdousi M, Kumar M, Cuthbertson DJ, et al. Diabetic peripheral neuropathy: epidemiology, diagnosis, and pharmacotherapy. Clin Ther. 2018;40:828–49. https://doi.org/10.1016/j.clinthera.2018.04.001
Valeyre D, Prasse A, Nunes H, Uzunhan Y, Brillet PY, Müller-Quernheim J. Sarcoidosis. Lancet. 2014;383:1155–67. https://doi.org/10.1016/S0140-6736(13)60680-7
Cortese A, Tozza S, Yau WY, Rossi S, Beecroft SJ, Jaunmuktane Z, et al. Cerebellar ataxia, neuropathy, vestibular areflexia syndrome due to RFC1 repeat expansion. Brain. 2020;143:480–90. https://doi.org/10.1093/brain/awz418
Mathis S, Duval F, Soulages A, Solé G, Le Masson G. The ataxic neuropathies. J Neurol. 2021;268:3675–89. https://doi.org/10.1007/s00415-020-09994-y
Levine TD. Small fiber neuropathy: disease classification beyond pain and burning. J Cent Nerv Syst Dis. 2018;10:1179573518771703. https://doi.org/10.1177/1179573518771703
Terkelsen AJ, Karlsson P, Lauria G, Freeman R, Finnerup NB, Jensen TS. The diagnostic challenge of small fibre neuropathy: clinical presentations, evaluations, and causes. Lancet Neurol. 2017;16:934–44. https://doi.org/10.1016/S1474-4422(17)30329-0
Tavee J, Zhou L. Small fiber neuropathy: A burning problem. Cleve Clin J Med. 2009;76:297–305. https://doi.org/10.3949/ccjm.76a.08070
Gwathmey KG. Sensory neuronopathies. Muscle Nerve. 2016;53:8–19. https://doi.org/10.1002/mus.24943
Cheshire WP. Autonomic history, examination, and laboratory evaluation. Continuum (Minneap Minn). 2020;26:25–43. https://doi.org/10.1212/CON.0000000000000815
Freeman R. Autonomic peripheral neuropathy. Continuum (Minneap Minn). 2020;26:58–71. https://doi.org/10.1212/CON.0000000000000825
Vernino S. Autoimmune autonomic disorders. Continuum (Minneap Minn). 2020;26:44–57. https://doi.org/10.1212/CON.0000000000000812
Rutkove S. Overview of polyneuropathy. UpToDate 2022. 2023 Dic 1. https://www.uptodate.com/contents/overview-of-polyneuropathy
England JD, Gronseth GS, Franklin G, Carter GT, Kinsella LJ, Cohen JA, et al. Evaluation of distal symmetric polyneuropathy: the role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review). Muscle Nerve. 2009;39:106–15. https://doi.org/10.1002/mus.21227
Siao P, Kaku M. A Clinician’s approach to peripheral neuropathy. Semin Neurol. 2019;39:519–30. https://doi.org/10.1055/s-0039-1694747
Doughty CT, Seyedsadjadi R. Approach to peripheral neuropathy for the primary care clinician. Am J Med. 2018;131:1010–6. https://doi.org/10.1016/j.amjmed.2017.12.042
Rögnvaldsson S, Steingrímsson V, Turesson I, Björkholm M, Landgren O, Yngvi Kristinsson S. Peripheral neuropathy and monoclonal gammopathy of undetermined significance: a population-based study including 15,351 cases and 58,619 matched controls. Haematologica. 2020;105:2679–81. https://doi.org/10.3324/haematol.2019.239632
Chopra GS, Gupta PK, Mishra DK. Evaluation of suspected monoclonal gammopathies: experience in a tertiary care hospital. Med J Armed Forces India. 2006;62:134–7. https://doi.org/10.1016/S0377-1237(06)80055-9
Ruth A, Schulmeyer FJ, Roesch M, Woertgen C, Brawanski A. Diagnostic and therapeutic value due to suspected diagnosis, long-term complications, and indication for sural nerve biopsy. Clin Neurol Neurosurg. 2005;107:214–7. https://doi.org/10.1016/j.clineuro.2004.08.004
Freynhagen R, Edwards RE, Calderón Ospina CA. Selección del tratamiento del dolor y la neuropatía periférica en todo el espectro: de los hechos a la realidad. Medscape. 2022 Feb 15. https://www.medscape.org/viewarticle/968183?src=soc_lk_share
Hoffman EM, Watson JC, St Sauver J, Staff NP, Klein CJ. Association of long-term opioid therapy with functional status, adverse outcomes, and mortality among patients with polyneuropathy. JAMA Neurol. 2017;74:773–9. https://doi.org/10.1001/jamaneurol.2017.0486
Arcila JJG. Guía práctica clínica: tratamiento con opioides dolor crónico no oncológico en población adulta y pediátrica en Colombia. Ministerio de Salud y Protección Social. Fondo Nacional de estupefacientes; 2022. https://consultorsalud.com/wp-content/uploads/2022/08/GPC-DCNO-Version-profesionales-de-la-salud-2022-08-23.pdf
Liampas A, Rekatsina M, Vadalouca A, Paladini A, Varrassi G, Zis P. Pharmacological management of painful peripheral neuropathies: a systematic review. Pain Ther. 2021;10:55–68. https://doi.org/10.1007/s40122-020-00210-3
Wiffen PJ, Derry S, Moore RA, Kalso EA. Carbamazepine for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev. 2014;2014:CD005451. https://doi.org/10.1002/14651858.CD005451.pub3
Finnerup NB, Attal N, Haroutounian S, McNicol E, Baron R, Dworkin RH, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015;14:162–73. https://doi.org/10.1016/S1474-4422(14)70251-0
Colloca L, Ludman T, Bouhassira D, Baron R, Dickenson AH, Yarnitsky D, et al. Neuropathic pain. Nat Rev Dis Primers. 2017;3:17002. https://doi.org/10.1038/nrdp.2017.2
Araya EI, Claudino RF, Piovesan EJ, Chichorro JG. Trigeminal neuralgia: basic and clinical aspects. Curr Neuropharmacol. 2020;18:109–19. https://doi.org/10.2174/1570159X17666191010094350
Szok D, Tajti J, Nyári A, Vécsei L. Therapeutic approaches for peripheral and central neuropathic pain. Behav Neurol. 2019;2019:8685954. https://doi.org/10.1155/2019/8685954
Finnerup NB, Sindrup SH, Jensen TS. The evidence for pharmacological treatment of neuropathic pain. Pain. 2010;150:573–81. https://doi.org/10.1016/j.pain.2010.06.019
Cavalli E, Mammana S, Nicoletti F, Bramanti P, Mazzon E. The neuropathic pain: An overview of the current treatment and future therapeutic approaches. Int J Immunopathol Pharmacol. 2019;33:2058738419838383. https://doi.org/10.1177/2058738419838383
Tofthagen C, Visovsky C, Berry DL. Strength and balance training for adults with peripheral neuropathy and high risk of fall: current evidence and implications for future research. Oncol Nurs Forum. 2012;39:E416–24. https://doi.org/10.1188/12.ONF.E416-E424
Finnerup NB, Otto M, McQuay HJ, Jensen TS, Sindrup SH. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain. 2005;118:289–305. https://doi.org/10.1016/j.pain.2005.08.013
Kumar N. Nutritional neuropathies. Neurol Clin. 2007;25:209–55. https://doi.org/10.1016/j.ncl.2006.11.001
Kirkland JB, Meyer-Ficca ML. Niacin. Adv Food Nutr Res. 2018;83:83–149. https://doi.org/10.1016/bs.afnr.2017.11.003
Hadtstein F, Vrolijk M. Vitamin B-6-induced neuropathy: exploring the mechanisms of pyridoxine toxicity. Adv Nutr. 2021;12:1911–29. https://doi.org/10.1093/advances/nmab033
Paez-Hurtado AM, Calderon-Ospina CA, Nava-Mesa MO. Mechanisms of action of vitamin B1 (thiamine), B6 (pyridoxine), and B12 (cobalamin) in pain: a narrative review. Nutr Neurosci. 2023;26:235–53. https://doi.org/10.1080/1028415X.2022.2034242
Gwathmey KG, Grogan J. Nutritional neuropathies. Muscle Nerve. 2020;62:13–29. https://doi.org/10.1002/mus.26783
Adamolekun B. Thiamine deficiency and the etiology of tropical ataxic neuropathy. Int Health. 2010;2:17–21. https://doi.org/10.1016/j.inhe.2009.12.004
Hammond N, Wang Y, Dimachkie MM, Barohn RJ. Nutritional neuropathies. Neurol Clin. 2013;31:477–89. https://doi.org/10.1016/j.ncl.2013.02.002
Ghavanini AA, Kimpinski K. Revisiting the evidence for neuropathy caused by pyridoxine deficiency and excess. J Clin Neuromuscul Dis 2014;16:25–31. https://doi.org/10.1097/CND.0000000000000049
Brown MJ, Ameer MA, Beier K. Vitamin B6 deficiency. StatPearls, Treasure Island (FL): StatPearls Publishing; 2022.
Vrolijk MF, Opperhuizen A, Jansen EHJM, Hageman GJ, Bast A, Haenen GRMM. The vitamin B6 paradox: Supplementation with high concentrations of pyridoxine leads to decreased vitamin B6 function. Toxicol In Vitro. 2017;44:206–12. https://doi.org/10.1016/j.tiv.2017.07.009
EFSA. Summary of tolerable upper intake levels-version 4 (overview on tolerable upper intake levels as derived by the Scientific Committee on Food (SCF) and the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). EFSA; 2018.
Kumar N. Neurologic aspects of cobalamin (B12) deficiency. Handb Clin Neurol. 2014;120:915–26. https://doi.org/10.1016/B978-0-7020-4087-0.00060-7
Hunt A, Harrington D, Robinson S. Vitamin B12 deficiency. BMJ. 2014;349:g5226. https://doi.org/10.1136/bmj.g5226
Bell DSH. Metformin-induced vitamin B12 deficiency presenting as a peripheral neuropathy. South Med J. 2010;103:265–7. https://doi.org/10.1097/SMJ.0b013e3181ce0e4d
Bell DSH. Metformin-induced vitamin B12 deficiency can cause or worsen distal symmetrical, autonomic and cardiac neuropathy in the patient with diabetes. Diabetes Obes Metab. 2022;24:1423–8. https://doi.org/10.1111/dom.14734
Bauman WA, Shaw S, Jayatilleke E, Spungen AM, Herbert V. Increased intake of calcium reverses vitamin B12 malabsorption induced by metformin. Diabetes Care. 2000;23:1227–31. https://doi.org/10.2337/diacare.23.9.1227
Stein J, Geisel J, Obeid R. Association between neuropathy and B-vitamins: A systematic review and meta-analysis. Eur J Neurol. 2021;28:2054–64. https://doi.org/10.1111/ene.14786
Pavlov CS, Damulin I V, Shulpekova YO, Andreev EA. Neurological disorders in vitamin B12 deficiency. Ter Arkh. 2019;91:122–9. https://doi.org/10.26442/00403660.2019.04.000116
Ahmed MA. Metformin and vitamin B12 deficiency: Where do we stand? J Pharm Pharm Sci. 2016;19:382–98. https://doi.org/10.18433/J3PK7P
Galvin R, Bråthen G, Ivashynka A, Hillbom M, Tanasescu R, Leone MA, et al. EFNS guidelines for diagnosis, therapy and prevention of Wernicke encephalopathy. Eur J Neurol. 2010;17:1408–18. https://doi.org/10.1111/j.1468-1331.2010.03153.x
Wiley KD, Gupta M. Vitamin B1 thiamine deficiency. StatPearls, Treasure Island (FL): StatPearls Publishing; 2022.
Thomson AD, Cook CCH, Touquet R, Henry JA, Royal College of Physicians London. The Royal College of Physicians report on alcohol: guidelines for managing Wernicke’s encephalopathy in the accident and Emergency Department. Alcohol Alcohol. 2002;37:513–21. https://doi.org/10.1093/alcalc/37.6.513
Stroh C, Meyer F, Manger T. Beriberi, a severe complication after metabolic surgery - review of the literature. Obes Facts. 2014;7:246–52. https://doi.org/10.1159/000366012
Corken M, Porter J. Is vitamin B6 deficiency an under-recognised risk in patients receiving haemodialysis? A systematic review: 2000-2010. Nephrology (Carlton). 2011;16(7):619-25. https://doi.org/10.1111/j.1440-1797.2011.01479.x
Staff NP, Windebank AJ. Peripheral neuropathy due to vitamin deficiency, toxins, and medications. Continuum (Minneap Minn). 2014;20:1293–306. https://doi.org/10.1212/01.CON.0000455880.06675.5a
Andrès E, Dali-Youcef N, Vogel T, Serraj K, Zimmer J. Oral cobalamin (vitamin B(12)) treatment. An update. Int J Lab Hematol. 2009;31:1–8. https://doi.org/10.1111/j.1751-553X.2008.01115.x
Vidal-Alaball J, Butler CC, Cannings-John R, Goringe A, Hood K, McCaddon A, et al. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency. Cochrane Database Syst Rev. 2005:CD004655. https://doi.org/10.1002/14651858.CD004655.pub2
Hakim M, Kurniani N, Pinzon RT, Tugasworo D, Basuki M, Haddani H, et al. Management of peripheral neuropathy symptoms with a fixed dose combination of high-dose vitamin B1, B6 and B12: A 12-week prospective non-interventional study in Indonesia. Asian J Med Sci. 2018;9:32–40. https://doi.org/10.3126/ajms.v9i1.18510
Sun Y, Lai MS, Lu CJ. Effectiveness of vitamin B12 on diabetic neuropathy: systematic review of clinical controlled trials. Acta Neurol Taiwan. 2005;14:48–54.
Wang JY, Wu YH, Liu SJ, Lin YS, Lu PH. Vitamin B12 for herpetic neuralgia: A meta-analysis of randomised controlled trials. Complement Ther Med. 2018;41:277–82. https://doi.org/10.1016/j.ctim.2018.10.014
Zhang M, Han W, Hu S, Xu H. Methylcobalamin: a potential vitamin of pain killer. Neural Plast. 2013;2013:424651. https://doi.org/10.1155/2013/424651
Calderon-Ospina CA, Nava-Mesa MO, Arbeláez Ariza CE. Effect of combined diclofenac and B vitamins (thiamine, pyridoxine, and cyanocobalamin) for low back pain management: systematic review and meta-analysis. Pain Medicine. 2020;21:766–81. https://doi.org/10.1093/pm/pnz216
Nava-Mesa MO, Aispuru Lanche GR. Papel de las vitaminas B, tiamina, piridoxina y cianocobalamina en el dolor de espalda y otras condiciones musculoesqueléticas: revisión narrativa. Semergen. 2021;47:551–62. https://doi.org/10.1016/j.semerg.2021.01.010
Janka HU, Rietzel S, Mehnert H. Der Einfluß von Neurobion auf die Temperatursensibilität bei Patienten mit diabetischer Polyneuropathie. En: Rietbrock N, editor. Pharmakologie und klinische Anwendung hochdosierter B-Vitamine, Heidelberg: Steinkopff; 1991. p. 87–97. https://doi.org/10.1007/978-3-642-85410-1_9
Jolivalt CG, Mizisin LM, Nelson A, Cunha JM, Ramos KM, Bonke D, et al. B vitamins alleviate indices of neuropathic pain in diabetic rats. Eur J Pharmacol. 2009;612:41–7. https://doi.org/10.1016/j.ejphar.2009.04.028
Jacobs AM, Cheng D. Management of diabetic small-fiber neuropathy with combination L-methylfolate, methylcobalamin, and pyridoxal 5’-phosphate. Rev Neurol Dis. 2011;8:39–47.
Rotaru A, TÂrtea GC, Ianc?u M. The neuroprotective role of alpha thioctic acid and vitamin B complex in diabetic neuropathy - an experimental study. Curr Health Sci J. 2020;46:150–5. https://doi.org/10.12865/CHSJ.46.02.08
Mimenza Alvarado A, Aguilar Navarro S. Clinical trial assessing the efficacy of gabapentin plus B complex (B1/B12) versus pregabalin for treating painful diabetic neuropathy. J Diabetes Res. 2016;2016:4078695. https://doi.org/10.1155/2016/4078695
Hakim, M, Kurniani, Pinzon R, Tugasworo D, Basuki M, Haddani H, Pambudi P, Fithrie A, Wuysang AD. A Review on prevalence and causes of peripheral neuropathy and treatment of different etiologic subgroups with neurotropic B vitamins. J Clin Exper Pharmacol. 2019;9. https://doi.org/10.35248/2161-1459.19.9.262
Karaganis S, Song XJ. B vitamins as a treatment for diabetic pain and neuropathy. J Clin Pharm Ther. 2021;46:1199–212. https://doi.org/10.1111/jcpt.13375
Gasperi V, Sibilano M, Savini I, Catani MV. Niacin in the central nervous system: an update of biological aspects and clinical applications. Int J Mol Sci. 2019;20:974. https://doi.org/10.3390/ijms20040974
Han Y, Wang M, Shen J, Zhang Z, Zhao M, Huang J, et al. Differential efficacy of methylcobalamin and alpha-lipoic acid treatment on symptoms of diabetic peripheral neuropathy. Minerva Endocrinol. 2018;43:11–8. https://doi.org/10.23736/S0391-1977.16.02505-0
Didangelos T, Karlafti E, Kotzakioulafi E, Kontoninas Z, Margaritidis C, Giannoulaki P, et al. Efficacy and safety of the combination of superoxide dismutase, alpha lipoic acid, vitamin B12, and carnitine for 12 months in patients with diabetic neuropathy. Nutrients. 2020;12:3254. https://doi.org/10.3390/nu12113254
Roy RP, Ghosh K, Ghosh M, Acharyya A, Bhattacharya A, Pal M, et al. Study of vitamin B12 deficiency and peripheral neuropathy in metformin-treated early type 2 diabetes mellitus. Indian J Endocrinol Metab. 2016;20:631–7. https://doi.org/10.4103/2230-8210.190542
Loew D, Wanitschke R, Schroedter A. Studies on vitamin B12 status in the elderly–prophylactic and therapeutic consequences. Int J Vitam Nutr Res. 1999;69:228–33. https://doi.org/10.1024/0300-9831.69.3.228
Rizzo G, Laganà AS, Rapisarda AMC, La Ferrera GMG, Buscema M, Rossetti P, et al. Vitamin B12 among vegetarians: status, assessment and supplementation. Nutrients. 2016;8:767. https://doi.org/10.3390/nu8120767
Karedath J, Batool S, Arshad A, Khalique S, Raja S, Lal B, et al. The impact of vitamin B12 supplementation on clinical outcomes in patients with diabetic neuropathy: a meta-analysis of randomized controlled trials. Cureus. 2022. https://doi.org/10.7759/cureus.31783
Li S, Guo Y, Men J, Fu H, Xu T. The preventive efficacy of vitamin B supplements on the cognitive decline of elderly adults: a systematic review and meta-analysis. BMC Geriatr. 2021;21:367. https://doi.org/10.1186/s12877-021-02253-3
Ankar A, Kumar A. Vitamin B12 deficiency. StatPearls, Treasure Island (FL): StatPearls Publishing; 2022.
Ang CD, Alviar MJM, Dans AL, Bautista-Velez GGP, Villaruz-Sulit MVC, Tan JJ, et al. Vitamin B for treating peripheral neuropathy. Cochrane Database Syst Rev. 2008:CD004573. https://doi.org/10.1002/14651858.CD004573.pub3
Jayabalan B, Low LL. Vitamin B supplementation for diabetic peripheral neuropathy. Singapore Med J. 2016;57:55–9. https://doi.org/10.11622/smedj.2016027
Pratama S, Lauren BC, Wisnu W. The efficacy of vitamin B12 supplementation for treating vitamin B12 deficiency and peripheral neuropathy in metformin-treated type 2 diabetes mellitus patients: A systematic review. Diabetes Metab Syndr. 2022;16:102634. https://doi.org/10.1016/j.dsx.2022.102634
Ahmad I, Hussain W. Stability of cyanocobalamin in parenteral preparations. Pak J Pharm Sci. 1993;6:53–9.
Monajjemzadeh F, Ebrahimi F, Zakeri-Milani P, Valizadeh H. Effects of formulation variables and storage conditions on light protected vitamin B12 mixed parenteral formulations. Adv Pharm Bull. 2014;4:329–38. https://doi.org/10.5681/apb.2014.048
McLaughlin K, Joyal K, Lee S, Corrado M, Marquis K, Anger K, et al. Safety of intravenous push thiamine administration at a tertiary academic medical center. J Am Pharm Assoc. (2003) 2020;60:598–601. https://doi.org/10.1016/j.japh.2019.12.005
Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, its Panel on Folate Other B Vitamins, Choline. Dietary reference intakes for thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin, and choline. Washington (DC): National Academies Press (US); 1998.
Calderon-Ospina CA, Nava-Mesa MO, Paez-Hurtado AM. Update on safety profiles of vitamins B1, B6, and B12: A narrative review. Ther Clin Risk Manag. 2020;16:1275–88. https://doi.org/10.2147/TCRM.S274122
National Institutes of Health, Office of Dietary Supplements. Vitamin B6. https://ods.od.nih.gov/factsheets/VitaminB6-Consumer/
National Institutes of Health, National Library of Medicine, PubChem. https://pubchem.ncbi.nlm.nih.gov/compound/Pyridoxine
van Hunsel F, van de Koppel S, van Puijenbroek E, Kant A. Vitamin B6 in health supplements and neuropathy: case series assessment of spontaneously reported cases. Drug Saf. 2018;41:859–69. https://doi.org/10.1007/s40264-018-0664-0
Balta I, Ozuguz P. Vitamin B12-induced acneiform eruption. Cutan Ocul Toxicol. 2014;33:94–5. https://doi.org/10.3109/15569527.2013.808657
National Institutes of Health, National Library of Medicine, PubChem. Cyanocobalamin (Vitamin B12). https://pubchem.ncbi.nlm.nih.gov/compound/Cyanocobalamin-_Vitamin-B12
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.